Loncastuximab tesirine in relapsed/refractory high-grade B-cell lymphoma: a subgroup analysis from the LOTIS-2 study

Autor:	Juan P. Alderuccio, Weiyun Z. Ai, John Radford, Melhem Solh, Kirit M. Ardeshna, Matthew A. Lunning, Brian T. Hess, Pier L. Zinzani, Anastasios Stathis, Carmelo Carlo-Stella, Mehdi Hamadani, Brad S. Kahl, David Ungar, Turk Kilavuz, Eric Yu, Yajuan Qin, Paolo F. Caimi
Rok vydání:	2022
Předmět:	Benzodiazepines Manchester Cancer Research Centre ResearchInstitutes_Networks_Beacons/mcrc Humans Lymphoma Large B-Cell Diffuse Hematology Neoplasm Recurrence Local Antibodies Monoclonal Humanized
Zdroj:	Alderuccio, J P, Ai, W Z, Radford, J, Solh, M M, Ardeshna, K M, Lunning, M, Hess, B, Luigi Zinzani, P, Stathis, A, Carlo Stella, C, Hamadani, M, Kahl, B S, Ungar, D, Kilavuz, T, Yu, E, Qin, Y G & Caimi, P F 2022, ' Loncastuximab tesirine in relapsed/refractory high-grade B-cell lymphoma : a subgroup analysis from the LOTIS-2 study ', Blood Advances, vol. 6, no. 16, pp. 4736-4739 . https://doi.org/10.1182/bloodadvances.2022007782
ISSN:	2473-9537 2473-9529
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::08bd9d4d9eea52ddc1ec3d548dcc2c67 https://doi.org/10.1182/bloodadvances.2022007782 Zobrazit plný text záznamu